- Q3 revenue increased 5.4% YoY to $108.4 billion; GAAP diluted EPS swung to $1.68 from -$3.13.
- Q3 adjusted diluted EPS reached $2.09 vs. $1.60 in the prior-year quarter.
- Full-year 2026 Adjusted EPS guidance raised to at least $8.20 (prior range: $7.90 to $8.10).
Signal #128366 · SEC 8-K
$CVS SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $CVS filing catalyst
Why did $CVS trigger an AI stock catalyst alert?
$CVS triggered a Stock Catalyst AI alert on 2026-11-04 00:00:00 UTC for a SEC 8-K filing (AI Score: +6.5/10). Headline: CVS Health Reports Q3 Adj. EPS of $2.09, Raises FY26 Guidance to at Least $8.20. Key points: - Q3 revenue increased 5.4% YoY to $108.4 billion; GAAP diluted EPS swung to $1.68 from -$3.13. - Q3 adjusted diluted EPS reached $2.09 vs. $1.60 in the prior-year quarter. - Full-year 2026 Adjusted EPS guidance raised to at least $8.20 (prior range: $7.90 to $8.10).
How did $CVS stock react after the SEC filing?
After the SEC 8-K for $CVS, observed market reaction: T0 price $91.41; peak move +2.26%. Past moves do not guarantee future results.
Where can I get real-time $CVS SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $CVS via Telegram and the VIP Web Terminal from €10/month.